Our client had a specific need to develop and build a highly effective team of key account managers (KAMs) and Medical Science Liaisons (MSLs) in the UK and EU4 with experience and expertise in the relevant rare disease areas.
Following in-depth scoping meetings, Inizio Engage worked closely with the client to define the optimum levels of support for commercial endeavors as well as providing KOLs with peer-to-peer level medical expertise.
Recruiting MSLs with the appropriate background can be a challenge for any business – we delivered on this in the key European markets in time for pre-launch activities.
Inizio Engage recruited and trained KAMs with the appropriate experience and educational background to focus on specific targeted physicians in the rare disease space.
We provided the in-country infrastructure along with the above-country governance, without the need for the client to build in-house infrastructure in each market.
The partnership continues to be a success, in some countries so successful that individuals initially employed by Inizio Engage have been taken in-house.
CASE STUDY (US) Seamless transition of US Medical Information program handled 98K calls within the first year.
Read moreCASE STUDY (US) Improved training program for rare-disease medication increases enrollment by 63%, with 25% increase in in-person training.
Read moreCASE STUDY (US) Device/reimbursement specialists successfully improve conversion rates, abandonment and speed to fill for medical device product.
Read more